Alternative splicing and cell survival: from tissue homeostasis to disease

Maria Paola Paronetto, Ilaria Passacantilli, Claudio Sette

Research output: Contribution to journalArticle

Abstract

Most human genes encode multiple mRNA variants and protein products through alternative splicing of exons and introns during pre-mRNA processing. In this way, alternative splicing amplifies enormously the coding potential of the human genome and represents a powerful evolutionary resource. Nonetheless, the plasticity of its regulation is prone to errors and defective splicing underlies a large number of inherited and sporadic diseases, including cancer. One key cellular process affected by alternative splicing is the programmed cell death or apoptosis. Many apoptotic genes encode for splice variants having opposite roles in cell survival. This regulation modulates cell and tissue homeostasis and is implicated in both developmental and pathological processes. Furthermore, recent evidence has also unveiled splicing-mediated regulation of genes involved in autophagy, another essential process for tissue homeostasis. In this review, we highlight some of the best-known examples of alternative splicing events involved in cell survival. Emphasis is given to the role of this regulation in human cancer and in the response to chemotherapy, providing examples of how alternative splicing of apoptotic genes can be exploited therapeutically.Cell Death and Differentiation advance online publication, 30 September 2016; doi:10.1038/cdd.2016.91.

Original languageEnglish
JournalCell Death and Differentiation
DOIs
Publication statusAccepted/In press - Sep 30 2016

Fingerprint

Alternative Splicing
Cell Survival
Homeostasis
Genes
Cell Death
RNA Precursors
Autophagy
Human Genome
Pathologic Processes
Introns
Publications
Cell Differentiation
Exons
Neoplasms
Apoptosis
Drug Therapy
Messenger RNA
Proteins

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Alternative splicing and cell survival : from tissue homeostasis to disease. / Paronetto, Maria Paola; Passacantilli, Ilaria; Sette, Claudio.

In: Cell Death and Differentiation, 30.09.2016.

Research output: Contribution to journalArticle

@article{9dbf1f002d3e42438acb272b20eec154,
title = "Alternative splicing and cell survival: from tissue homeostasis to disease",
abstract = "Most human genes encode multiple mRNA variants and protein products through alternative splicing of exons and introns during pre-mRNA processing. In this way, alternative splicing amplifies enormously the coding potential of the human genome and represents a powerful evolutionary resource. Nonetheless, the plasticity of its regulation is prone to errors and defective splicing underlies a large number of inherited and sporadic diseases, including cancer. One key cellular process affected by alternative splicing is the programmed cell death or apoptosis. Many apoptotic genes encode for splice variants having opposite roles in cell survival. This regulation modulates cell and tissue homeostasis and is implicated in both developmental and pathological processes. Furthermore, recent evidence has also unveiled splicing-mediated regulation of genes involved in autophagy, another essential process for tissue homeostasis. In this review, we highlight some of the best-known examples of alternative splicing events involved in cell survival. Emphasis is given to the role of this regulation in human cancer and in the response to chemotherapy, providing examples of how alternative splicing of apoptotic genes can be exploited therapeutically.Cell Death and Differentiation advance online publication, 30 September 2016; doi:10.1038/cdd.2016.91.",
author = "Paronetto, {Maria Paola} and Ilaria Passacantilli and Claudio Sette",
year = "2016",
month = "9",
day = "30",
doi = "10.1038/cdd.2016.91",
language = "English",
journal = "Cell Death and Differentiation",
issn = "1350-9047",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Alternative splicing and cell survival

T2 - from tissue homeostasis to disease

AU - Paronetto, Maria Paola

AU - Passacantilli, Ilaria

AU - Sette, Claudio

PY - 2016/9/30

Y1 - 2016/9/30

N2 - Most human genes encode multiple mRNA variants and protein products through alternative splicing of exons and introns during pre-mRNA processing. In this way, alternative splicing amplifies enormously the coding potential of the human genome and represents a powerful evolutionary resource. Nonetheless, the plasticity of its regulation is prone to errors and defective splicing underlies a large number of inherited and sporadic diseases, including cancer. One key cellular process affected by alternative splicing is the programmed cell death or apoptosis. Many apoptotic genes encode for splice variants having opposite roles in cell survival. This regulation modulates cell and tissue homeostasis and is implicated in both developmental and pathological processes. Furthermore, recent evidence has also unveiled splicing-mediated regulation of genes involved in autophagy, another essential process for tissue homeostasis. In this review, we highlight some of the best-known examples of alternative splicing events involved in cell survival. Emphasis is given to the role of this regulation in human cancer and in the response to chemotherapy, providing examples of how alternative splicing of apoptotic genes can be exploited therapeutically.Cell Death and Differentiation advance online publication, 30 September 2016; doi:10.1038/cdd.2016.91.

AB - Most human genes encode multiple mRNA variants and protein products through alternative splicing of exons and introns during pre-mRNA processing. In this way, alternative splicing amplifies enormously the coding potential of the human genome and represents a powerful evolutionary resource. Nonetheless, the plasticity of its regulation is prone to errors and defective splicing underlies a large number of inherited and sporadic diseases, including cancer. One key cellular process affected by alternative splicing is the programmed cell death or apoptosis. Many apoptotic genes encode for splice variants having opposite roles in cell survival. This regulation modulates cell and tissue homeostasis and is implicated in both developmental and pathological processes. Furthermore, recent evidence has also unveiled splicing-mediated regulation of genes involved in autophagy, another essential process for tissue homeostasis. In this review, we highlight some of the best-known examples of alternative splicing events involved in cell survival. Emphasis is given to the role of this regulation in human cancer and in the response to chemotherapy, providing examples of how alternative splicing of apoptotic genes can be exploited therapeutically.Cell Death and Differentiation advance online publication, 30 September 2016; doi:10.1038/cdd.2016.91.

UR - http://www.scopus.com/inward/record.url?scp=84989244139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989244139&partnerID=8YFLogxK

U2 - 10.1038/cdd.2016.91

DO - 10.1038/cdd.2016.91

M3 - Article

AN - SCOPUS:84989244139

JO - Cell Death and Differentiation

JF - Cell Death and Differentiation

SN - 1350-9047

ER -